It has become apparent that apart from mutations on PIK3CA and TP53 loci, which dominate the mutational landscape of breast cancer samples [6, 7], there is a handful of genes which are recurrently mutated in at least 10% of the cases [6]. This evidence concerns the gene TP53 and breast carcinoma.